Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 1,477-1,488 of 10,612

Drug study icon

RecruitingNCT05850689

Lumateperone as Adjunctive Therapy in the Treatment of people with Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, France, Bulgaria, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Depression

Behavioral study icon

RecruitingNCT00018057

Neuro-Cognitive Correlates of Pediatric Anxiety Disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Depression, AnxietyBehavioralFrom 8 Years to 65 Years

Countries: United States
Sponsor: National Institute of Mental Health (NIMH)
Condition: Depression, Anxiety

Drug study icon

RecruitingNCT07520292

NTX-2001 on Alcohol Consumption in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 60 Years

Countries: United States
Sponsor: Newleos Therapeutics, Inc.
Condition: Addiction

Drug study icon

RecruitingNCT06399263

Psilocybin for Anorexia in Young Adults

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 25 Years

Countries: United States
Sponsor: Marissa Raymond-Flesch, MD, MPH
Condition: Eating disorders

Drug study icon

RecruitingNCT06671977

Safety study of Safety, Tolerability, Electrophysiological Effects and Efficacy of DMT in Depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

DepressionDrugFrom 21 Years to 65 Years

Countries: United States
Sponsor: Deepak C. D'Souza
Condition: Depression

Behavioral study icon

RecruitingNCT06727331

Tirzepatide for Recovery and Alcohol Use Management

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralOver 18 Years

Countries: United States
Sponsor: Brigham and Women's Hospital
Condition: Addiction

Behavioral study icon

RecruitingNCT06238700

Study on Allopregnanolone and Depression in Women Across the Menopause Transition

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionBehavioralFrom 40 Years to 60 Years

Countries: United States
Sponsor: Beth Israel Deaconess Medical Center
Condition: Depression

Behavioral study icon

RecruitingNCT06846320

Adverse Events and Change for anxiety

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AnxietyBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Anxiety

Drug study icon

RecruitingNCT07220460

Adverse Events of Oral ABBV-932 for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: AbbVie
Condition: Bipolarity, Depression

Drug study icon

RecruitingNCT06786624

NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Depression

Drug study icon

RecruitingNCT07467993

Safety, Tolerability, and Treatment Response of GXV813 for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States and in Bulgaria.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria
Sponsor: Novartis Pharmaceuticals
Condition: Schizophrenia

Drug study icon

RecruitingNCT06538558

Use of Tezampanel for Addiction

The registry lists this study as recruiting. Study locations are listed in the United States.

In United States

AddictionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Proniras Corporation
Condition: Addiction

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.